| Heading: |
Pregnancy: Immunosuppression |
| Question ID: |
1794414 |
| UIN: |
45787 |
| House: |
Commons |
| Date tabled: |
2025-04-17 |
| Asking Member ID: |
4616 |
| Asking Member display name: |
Rosie Duffield
|
| Asking Member handle: |
RosieDuffield1
|
| Asking Member Twitter reference: |
@RosieDuffield1
|
| Member interest: |
false |
| Question text: |
To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential impact of taking immunosuppressant drugs in cases of pregnancy after organ transplant on babies in utero. |
| Is named day: |
false |
| Date of holding answer: |
|
| Date answered: |
2025-04-28 |
| Date answer corrected: |
|
| Is holding answer: |
false |
| Is correcting answer: |
false |
| Answering Member ID: |
4981 |
| Answering Member display name: |
Ashley Dalton
|
| Answering Member handle: |
AshleyDalton_MP
|
| Answering Member Twitter reference: |
@AshleyDalton_MP
|
| Correcting Member ID: |
|
| Correcting Member display name: |
|
| Correcting Member handle: |
|
| Correcting Member Twitter reference: |
|
| Answer text: |
Some immunosuppressive drugs are known to cause a structural or functional change in the foetus, known as teratogenic drugs, and so this is a critical area of concern in transplant medicine, and discussion with a patient’s transplant team is important to ... |
| Original answer text: |
|
| Comparable answer text: |
|
| Answering body ID: |
17 |
| Answering body name: |
Department of Health and Social Care |
| Tweeted: |
true |